QurAlis

About:

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Twitter/X: QurAlisCo

Top Investors: Mission BioCapital, Polaris Partners, Dementia Discovery Fund, Alexandria Venture Investments, EQT Life Sciences

Description:

QurAlis is a clinical-stage biotechnology company that is developing precision medicines with genetically validated targets for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. Its proprietary platforms and biomarkers allow for the design and development of drugs that target disease-causing genetic alterations directly.

Total Funding Amount:

$136M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2016-12-12

Contact Email:

info(AT)quralis.com

Founders:

Clifford J Woolf, Kasper Roet, Kevin Eggan

Number of Employees:

101-250

Last Funding Date:

2023-03-09

IPO Status:

Private

Industries: